X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1711) 1711
Book Review (139) 139
Publication (45) 45
Book Chapter (9) 9
Conference Proceeding (4) 4
Dissertation (3) 3
Reference (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1443) 1443
humans (1065) 1065
female (708) 708
mesna (702) 702
oncology (650) 650
male (625) 625
adult (534) 534
ifosfamide - administration & dosage (513) 513
middle aged (507) 507
mesna - administration & dosage (473) 473
antineoplastic combined chemotherapy protocols - therapeutic use (467) 467
ifosfamide (427) 427
aged (363) 363
ifosfamide - adverse effects (322) 322
mesna - therapeutic use (312) 312
chemotherapy (301) 301
animals (258) 258
cyclophosphamide (234) 234
adolescent (228) 228
mercaptoethanol - analogs & derivatives (215) 215
antineoplastic combined chemotherapy protocols - adverse effects (211) 211
cancer (185) 185
mesna - pharmacology (179) 179
pharmacology & pharmacy (172) 172
ifosfamide - therapeutic use (171) 171
treatment outcome (169) 169
doxorubicin - administration & dosage (168) 168
mesna - metabolism (168) 168
child (163) 163
sarcoma - drug therapy (150) 150
etoposide - administration & dosage (147) 147
drug administration schedule (141) 141
rats (133) 133
mesna - adverse effects (129) 129
therapy (124) 124
cisplatin (122) 122
abridged index medicus (120) 120
cyclophosphamide - adverse effects (118) 118
combined modality therapy (116) 116
cyclophosphamide - administration & dosage (116) 116
mesna - analogs & derivatives (114) 114
cisplatin - administration & dosage (112) 112
hematology (112) 112
toxicity (111) 111
child, preschool (105) 105
infusions, intravenous (105) 105
cystitis - chemically induced (103) 103
dose-response relationship, drug (103) 103
doxorubicin (102) 102
neoplasms - drug therapy (101) 101
children (98) 98
antineoplastic combined chemotherapy protocols - administration & dosage (94) 94
vincristine - administration & dosage (91) 91
antineoplastic agents, alkylating - adverse effects (89) 89
lung neoplasms - drug therapy (89) 89
remission induction (86) 86
cystitis - prevention & control (83) 83
kinetics (83) 83
soft tissue neoplasms - drug therapy (82) 82
sarcoma (80) 80
survival rate (80) 80
mesna - chemistry (79) 79
pharmacokinetics (79) 79
survival analysis (79) 79
biochemistry & molecular biology (78) 78
phase-ii trial (78) 78
medicine & public health (74) 74
time factors (74) 74
antineoplastic agents, alkylating - administration & dosage (73) 73
mice (73) 73
trial (73) 73
drug evaluation (71) 71
pediatrics (70) 70
research (69) 69
carboplatin - administration & dosage (68) 68
obstetrics & gynecology (68) 68
protective agents - therapeutic use (67) 67
retrospective studies (66) 66
infant (65) 65
ovarian neoplasms - drug therapy (65) 65
phase-ii (65) 65
etoposide (62) 62
hemorrhage - chemically induced (62) 62
prevention (62) 62
surgery (62) 62
cystitis (61) 61
disease-free survival (61) 61
neoplasm staging (61) 61
adriamycin (60) 60
oxidoreductases - metabolism (60) 60
carcinoma (59) 59
nephrotoxicity (59) 59
drug therapy, combination (58) 58
high-dose ifosfamide (58) 58
oxidation-reduction (58) 58
hemorrhagic cystitis (57) 57
prospective studies (56) 56
antineoplastic agents, alkylating - therapeutic use (55) 55
combination chemotherapy (54) 54
urology & nephrology (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1609) 1609
German (32) 32
French (27) 27
Japanese (12) 12
Spanish (8) 8
Chinese (5) 5
Polish (5) 5
Russian (5) 5
Portuguese (4) 4
Turkish (4) 4
Czech (3) 3
Korean (3) 3
Dutch (2) 2
Italian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Comparison of uroprotective efficacy of mesna and amifostine in cyclophosphamide- induced hemorrhagic cystitis in rats, 12/2006
Background:Hemorrhagic cystitis (HC) is a dose limiting side effect of cyclophosphamide (CYP). AIM: In this study, we aimed to investigate the role of... 
Amifostine, cyclophosphamide, hemorrhagic cystitis, mesna
Journal
Journal Article
Journal Article
Journal Article
Biochemistry, ISSN 0006-2960, 11/2017, Volume 56, Issue 46, pp. 6137 - 6144
Here I report on the identification of 1-mercaptoethanesulfonic acid (1-MES), an analogue of 2-mercaptoethanesulfonic acid (coenzyme M, HSCoM). 1-MES and HSCoM... 
Methanococcus - enzymology | Methanococcus - growth & development | Methanococcus - metabolism | Biosynthetic Pathways | Mesna - analogs & derivatives | Sulfides - metabolism | Mesna - metabolism | Sulfonic Acids - metabolism | Ethylenes - metabolism | Deuterium | Chemical reactions | Usage | Chemical properties | Index Medicus
Journal Article